Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: United Arab Emirates Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20104
20112
20123
20132
20144
20153
20165
20173
20182
20192
20221
20233
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Unknown status4
Recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S13
Imperial College London Diabetes Centre5
Sanofi4
AstraZeneca3
Eli Lilly and Company3
Rashid Centre for Diabetes and Research3
Dr Adnan Agha1
GT Metabolic Solutions, Inc.1
Halia Therapeutics, Inc.1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 240
Diabetes Mellitus14
Diabetes Mellitus, Type 14
Obesity4
Glucose Metabolism Disorders2
Hypoglycemia2
Metabolic Diseases2
Renal Insufficiency, Chronic2
Acute Coronary Syndrome1
Diabetes, Gestational1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.